This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.
Ashtead (full-year earnings 7 March)
Ashtead seems ideally placed to benefit from Donald Trump’s stimulus programme in the US, even if we still have precious few details on the actual stimulus. Nonetheless, the firm’s big US operations have already fired up investor enthusiasm, with the shares surging since the election. The shares have delivered an increase in earnings in each of the last five years, while its strong record of dividends is matched by a dividend coverage ratio of four times earnings. Watch for further comment on the potential opportunities offered in the US as a consequence of the Trump stimulus.
The shares have barely stopped since the election, reaching a new all-time high at the beginning of March. We may see some profit-taking following the results, but so long as the price doesn’t breach £14 it seems likely Ashtead will remain an investor favourite. Some near-term support may be found at the 50-day simple moving average (SMA), currently £16.30.